NovelStem International Corp. (NSTM)

0.0095 0.00 (0.00%) USD  |  OTCM  |  Sep 11, 16:00
More

NovelStem International Price : 0.0095 for Sept. 11, 2026

Price Chart

View Price for NSTM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Chart
Start Trial

Historical Price Data

View and export this data back to 2018. Start Trial.
Date Open High Low Close Volume
Sep 11, 2026 0.0095 0.0095 0.0095 0.0095 0.000
Sep 10, 2026 0.0095 0.0095 0.0095 0.0095 0.000
Sep 09, 2026 0.0095 0.0095 0.0095 0.0095 0.000
Sep 08, 2026 0.0095 0.0095 0.0095 0.0095 0.000
Sep 04, 2026 0.0095 0.0104 0.0095 0.0095 8950.00
Sep 03, 2026 0.0095 0.0095 0.0095 0.0095 0.000
Sep 02, 2026 0.0095 0.0095 0.0095 0.0095 0.000
Sep 01, 2026 0.0095 0.0095 0.0095 0.0095 1000.00
Aug 31, 2026 0.0106 0.0106 0.0106 0.0106 1336.00
Aug 28, 2026 0.0095 0.0095 0.0095 0.0095 0.000
Aug 27, 2026 0.0095 0.0095 0.0095 0.0095 0.000
Aug 26, 2026 0.0095 0.0095 0.0095 0.0095 0.000
Aug 25, 2026 0.0095 0.0095 0.0095 0.0095 0.000
Aug 24, 2026 0.0095 0.0095 0.0095 0.0095 0.000
Aug 21, 2026 0.0085 0.0095 0.0085 0.0095 129940.0
Aug 20, 2026 0.0096 0.0096 0.0062 0.0062 387500.0
Aug 19, 2026 0.0115 0.0115 0.0115 0.0115 0.000
Aug 18, 2026 0.0115 0.0115 0.0115 0.0115 0.000
Aug 17, 2026 0.0115 0.0115 0.0115 0.0115 0.000
Aug 14, 2026 0.0115 0.0115 0.0115 0.0115 0.000
Aug 13, 2026 0.0115 0.0115 0.0115 0.0115 0.000
Aug 12, 2026 0.0115 0.0115 0.0115 0.0115 0.000
Aug 11, 2026 0.0115 0.0115 0.0115 0.0115 0.000
Aug 10, 2026 0.0115 0.0115 0.0115 0.0115 0.000
Aug 07, 2026 0.0115 0.0115 0.0115 0.0115 0.000

Price Definition

The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).

Read full definition.

Price Range, Past 5 Years

View Price Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Benchmarks

View Price Benchmarks
Start Trial
Brainstorm Cell Therapeutics, Inc. 1.08
Summit Therapeutics, Inc. 17.55
Kezar Life Sciences, Inc. 7.29
Protara Therapeutics, Inc. 3.82
Clene, Inc. 3.57

Price Related Metrics

Earnings Yield -67.37%
Market Cap 0.4687M